Fig. 1From: Heterogeneity of treatment responses in rheumatoid arthritis using group based trajectory models: secondary analysis of clinical trial dataMean Disease Activity Profiles Over 12 Months In The Three Group Based Trajectory Models (Good, Moderate And Poor Responders)Means and 95% confidence intervals are shown.Back to article page